org placeholder image

Siminder Atwal

Executive Director, Clinical Development at Prelude Therapeutics

  • LinkedIn
map
PRELUDE THERAPEUTICS

PRELUDE THERAPEUTICS

  • description Description
    Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. The Companys diverse pipeline is comprised o...

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 25 Million to 50 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Prelude Therapeutics Org Chart and Mapping

Kris Vaddi

Chief Executive Officer and Founder

VP-Level
VP-Level
Employees

Komali Vykuntam

Senior Research Associate

Brittany Teal

Senior Director of Accounting

Siminder Atwal

Executive Director, Clinical Development

Murty Mangena

Executive Director, Technical Operations

Song Mei

Senior Research Scientist

Frequently Asked Questions Regarding Siminder Atwal

Answer: Siminder Atwal works for Prelude Therapeutics as Executive Director, Clinical Development

Answer: Siminder Atwal’s role in Prelude Therapeutics is Executive Director, Clinical Development

Answer: Siminder Atwal's email address is s***@gmail.com

Answer: Siminder Atwal's business email address is s****@fatetherapeutics.com

Answer: Siminder Atwal’s direct phone number is (***)-***-****

Answer: Siminder Atwal works in the industry of: Biotechnology

Answer: Siminder Atwal works Prelude Therapeutics located at 200 Powder ML Rd, Wilmington, Delaware, 19803, United States

Answer: Prelude Therapeutics's Executive Director, Clinical Development is Siminder Atwal

Answer: Siminder Atwal contact details:

  • Phone number  :  (***)-***-****
  • Email  :  s****@fatetherapeutics.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access